Stage IV Ovarian Cancer Completed Phase 2 Trials for Cyclophosphamide (DB00531)

IndicationStatusPhase
DBCOND0030167 (Stage IV Ovarian Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00072566Bevacizumab and Low-Dose Cyclophosphamide in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal CancerTreatment